Synthace
Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
About
Synthace provides a cloud platform that enables life sciences R&D teams to design, automate, and run powerful experiments. Their solution generates high-dimensional, fully contextualized datasets essential for AI-driven discovery, helping scientists cut time to insight by removing friction from experimental processes. They serve drug discovery and other life sciences R&D organizations. Teams look it up for Biotech, MedTech, HealthTech.
Frequently asked
What does Synthace do?
Synthace is a Biotech company that offers Platform. Teams look it up for MedTech, HealthTech, Drug Discovery. It is based in London, United Kingdom and was founded in 2011. Public records show about 37 people and $61M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Synthace raised?
Synthace has raised a total of $61M in funding. The most recent round on record is Series C.
Where is Synthace headquartered?
Synthace is headquartered in London, United Kingdom.
When was Synthace founded?
Synthace was founded in 2011.
What industry does Synthace operate in?
Synthace operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials.
How many employees does Synthace have?
Synthace has approximately 37 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.